Schedule 13G ownership disclosure

ARROWHEAD PHARMACEUTICALS INC COM

COMMON STOCK · CUSIP: 04280A100

Event date: 2025-06-30

Filing-level shares
6,371,056.00
Percent of class
4.6%
  • STATE STREET CORPORATION

    Shares: 6,371,056.00 · Class: 4.6%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000093751-25-000436
Form type
SCHEDULE 13G
Filer
ARROWHEAD PHARMACEUTICALS, INC.
CIK
CIK 879407
Filed
Aug 11, 2025
Reporting period
Jun 30, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub